麻黃附子細辛湯與智愛湯治療失智患者冬季憂鬱及冷漠症狀

Treatment of Depressive and Cold Symptoms of Dementia Patients with Ma- Huang-Fu-Zi-Xi-Xin-Tang and Zhi-Ai-Tang

10.6516/TJTCM.2017.20(1)13

陳美如(Mei-Ru Chen)；黃羽羚(Yu-Ling Huang)；謝旭東(Hsu-Tung Hsieh)；吳宿真(Su-Jhen Wu)；林舜穀(Shun-Ku Lin)

失智症 ； 憂鬱 ； 冷漠 ； 智愛湯 ； 麻黃附子細心湯 ； Dementia ； depression ； indifference ； Ma-Huang-Fu-Zi-Xi-Xin-Tang ； Zhi-Ai-Tang

中醫藥研究論叢

20卷1期（2017 / 03 / 30）

13 - 24

繁體中文

前言：憂鬱及冷漠是失智症患者常見精神症狀，尤以寒冷且光照較少的冬天更易出現。本研究探討併用麻黃附子細辛湯與智愛湯，對於失智症患者在冬季時的憂鬱及冷漠等症狀的療效。方法：招募2014年11月至2015年3月間，因失智症伴有明顯憂鬱或冷漠，而希望接受中醫治療的患者，用追蹤觀察法研究26名自願參與者的精神與神經學症狀進展。試驗前四週每位患者接受每日早晨服用中藥智愛湯一包（100ml），及一日兩次每次4克麻黃附子細辛湯濃縮中藥粉劑。治療後八週我們繼續使用智愛湯作維持治療，療效指標包含簡短版神經精神量表（NPI-Q）、簡易心智量表（MMSE）、工具性日常生活活動能力量表（IADL）與日常生活活動功能量表（ADL）。測量時間為治療開始前與治療後各作一次測量。結果：研究結束時共有24位參與者完成研究，參與者的NPI-Q總分及憂鬱、冷漠兩項分數明顯下降且達統計意義，ADL與IADL分數均顯著上升且達統計意義。在兩個月後續維持治療時，IADL、MMSE、NPI-Q總分與治療前差異不明顯，顯示治療效果在兩個月內能繼續維持。結論：本研究發現服用智愛湯合併麻黃附子細辛湯可減緩失智症患者的憂鬱及冷漠症狀，並能改善日常活動能力，但對於認知能力無顯著影響，建議未來可在失智症臨床照護上推廣使用。

Background: Depression and indifference are common psychiatric symptoms in people with dementia, especially in the cold and less sunny days are more likely to occur. This study explored the effects of combined use of Ma-Huang- Fu-Zi-Xi-Xin-Tang and Zhi-Ai-Tang on mental and behavioral symptoms such as depression and indifference during dementia in winter. Methods: We recruited patients with dementia associated with marked depression or indifference from November 2014 to March 2015, who were expecting to receive Chinese medicine treatment. The follow-up observation was used to study the status of medication and symptom progression in 26 volunteers. During the experiment, each patient received a package（100ml）of traditional Chinese medicine, Zhi-Ai-Tang, every morning, and four grams of Ma-Huang-Fu-Zi-Xi- Xin-Tang powder for four consecutive weeks. After treatment, we continued to use Chi Ai Tang for two months of maintenance therapy; curative effect indicators include a short version of neuropsychiatric scale（NPI-Q）, simple mental scale （MMSE）, instrumental activities of daily living scale IADL）and daily life function scale（ADL）. We Measured before and after the three-month treatment. Results: At the end of the study, a total of 24 participants completed the study, the participants of the NPI-Q score and depression, apathy two scores decreased significantly and statistical significance, ADL and IADL scores were significantly increased and reached statistical significance. In two months follow-up maintenance therapy, IADL、MMSE、NPI-Q score and the difference between the treatment is not apparent, showing that treatment can continue to maintain within two months. Conclusions: The study found that taking traditional Chinese medicine Ma- Huang-Fu-Zi-Xi-Xin-Tang and Zhi-Ai-Tang could slow dementia patients with depression and apathy symptoms and can improve the ability of daily activities, but no significant impact on cognitive ability, it is recommended to the future clinical dementia Care to promote the use.

1. 明薛己(2014)。保嬰撮要。中國中醫藥出版社。
2. 東漢張機(2013)。傷寒雜病論。中國醫藥科技出版社。
3. Bains, J,Birks, J,Dening, T(2002).Antidepressants for treating depression in dementia.Cochrane Database Syst Rev,CD003944.
4. Ballard, CG,Thomas, A,Fossey, J,Lee, L,Jacoby, R,Lana, MM,Bannister, C,McShane, R,Swann, A,Juszczak, E,O'Brien, JT(2004).A 3-month, randomized, placebocontrolled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.J Clin Psychiatry.,65(1),114-9.
5. Burns, A,Allen, H,Tomenson, B,Duignan, D,Byrne, J(2009).Bright light therapy for agitation in dementia: a randomized controlled trial.Int Psychogeriatr.,21(4),711-21.
6. Chen, YX,Li, GZ,Zhang, B,Xia, ZY,Zhang, M(2016).Molecular evaluation of herbal compounds as potent inhibitors of acetylcholinesterase for the treatment of Alzheimer's disease.Mol Med Rep.,14(1),446-52.
7. Clarke, DE,Reekum, Rv,Simard, M,Streiner, DL,Freedman, M,Conn, D(2007).Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale.J Neuropsychiatry Clin Neurosci.,19(1),57-64.
8. Enache, D,Winblad, B,Aarsland, D(2011).Depression in dementia: epidemiology, mechanisms, and treatment.Curr Opin Psychiatry.,24(6),461-72.
9. Folstein, MF,Folstein, SE,McHugh, PR(1975)."Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.J Psychiatr Res.,12(3),189-98.
10. García-Casal, JA,Loizeau, A,Csipke, E,Franco-Martín, M,Perea-Bartolomé, MV,Orrell, M(2016).Computer-based cognitive interventions for people living with dementia: a systematic literature review and meta-analysis.Aging Ment Health.,25,1-14.
11. Gitlin, LN,Kales, HC,Lyketsos, CG(2012).Nonpharmacologic management of behavioral symptoms in dementia.JAMA,308,2020.
12. Ikarashi, Y,Iizuka, S,Imamura, S(2009).Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiaminedeficient rats.Biol Pharm Bull.,32,1701-1709.
13. Ikeda, Y,Iizuka, A,Amagaya, S,Ishige, A,Komatsu, Y,Fujihira, E(2000).Anti-type I allergic mechanisms of mao-bushi-saishin-to in mice.Jpn J Pharmacol.,82(1),29-33.
14. Iwasaki, K,Maruyama, M,Tomita, N(2005).Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.J Clin Psychiatry.,66,1612-1613.
15. Iwasaki, K,Satoh-Nakagawa, T,Maruyama, M(2005).A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.J Clin Psychiatry,66,248-252.
16. Kamei, T,Nagura, S,Toriumi, Y,Kumano, H,Kondoh, T,Tomioka, H(2000).Effect of half the standard dose of Mao-bushi-saishin-to in two MRSA patients and one decubitus ulcer patient.Am J Chin Med.,28(2),301-4.
17. Kamei, T,Toriumi, Y,Tomioka, H(2000).Effect of Mao-bushi-saishin-to on infection of ofloxacin resistant bacteria and of unknown origin.Complement Ther Med.,8(4),276-9.
18. Kiosses, DN,Ravdin, LD,Gross, JJ,Raue, P,Kotbi, N,Alexopoulos, GS(2015).Problem adaptation therapy for older adults with major depression and cognitive impairment: a randomized clinical trial.JAMA Psychiatry,72,22.
19. Lyketsos, CG,Lee, HB(2004).Diagnosis and treatment of depression in Alzheimer's disease. A practical update for the clinician.Dement Geriatr Cogn Disord,17,55.
20. Lyketsos, CG,Lopez, O,Jones, B,Fitzpatrick, AL,Breitner, J,DeKosky, S(2002).Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.JAMA,288,1475.
21. Mao, HF,Kuo, CA,Huang, WN,Cummings, JL,Hwang, TJ(2015).Values of the Minimal Clinically Important Difference for the Neuropsychiatric Inventory Questionnaire in Individuals with Dementia.J Am Geriatr Soc.,63(7),1448-52.
22. Matsuda, Y,Kishi, T,Shibayama, H(2013).Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials.Hum Psychopharmacol.,28,80-86.
23. Miyaoka, T,Furuya, M,Yasuda, H(2008).Yi-gan san for the treatment of borderline personality disorder: an open-label study.Prog Neuropsychopharmacol Biol Psychiatry.,32,150-154.
24. Miyaoka, T,Furuya, M,Yasuda, H(2008).Yigan san for the treatment of neurolepticinduced tardive dyskinesia: an open-label study.Prog Neuropsychopharmacol Biol Psychiatry.,32,761-4.
25. Mizukami, K,Asada, T,Kinoshita, T(2009).A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.Int J Neuropsychopharmacol.,12,191-199.
26. Mizukami, K,Asada, T,Kinoshita, T,Tanaka, K,Sonohara, K,Nakai, R,Yamaguchi, K,Hanyu, H,Kanaya, K,Takao, T,Okada, M,Kudo, S,Kotoku, H,Iwakiri, M,Kurita, H,Miyamura, T,Kawasaki, Y,Omori, K,Shiozaki, K,Odawara, T,Suzuki, T,Yamada, S,Nakamura, Y,Toba, K(2009).A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.Int J Neuropsychopharmacol.,12,191-199.
27. O'Donnell, BF,Drachman, DA,Barnes, HJ,Peterson, KE,Swearer, JM,Lew, RA(1992).Incontinence and troublesome behaviors predict institutionalization in dementia.J Geriatr Psychiatry Neurol,5,45.
28. Olin, JT,Katz, IR,Meyers, BS,Schneider, LS,Lebowitz, BD(2002).Provisional diagnostic criteria for depression of Alzheimer disease.Am J Geriatr Psychiatry,10,125.
29. Peters, KR,Rockwood, K,Black, SE,Bouchard, R,Gauthier, S,Hogan, D,Kertesz, A,Loy-English, I,Beattie, BL,Sadovnick, AD,Feldman, HH(2006).Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics.Neurology,66,523.
30. Rosen, HJ,Allison, SC,Schauer, GF,Gorno-Tempini, ML,Weiner, MW,Miller, BL(2005).Neuroanatomical correlates of behavioural disorders in dementia.Brain,128,2612.
31. Ryu, SY,Lee, SB,Kim, TW,Lee, TJ(2015).Subjective memory complaints, depressive symptoms and instrumental activities of daily living in mild cognitive impairment.Int Psychogeriatr.,11,1-8.
32. Savva, GM,Zaccai, J,Matthews, FE,Davidson, JE,McKeith, I,Brayne, C(2009).Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population.Br J Psychiatry,194,212.
33. Scarmeas, N,Brandt, J,Blacker, D,Albert, M,Hadjigeorgiou, G,Dubois, B,Devanand, D,Honig, L,Stern, Y(2007).Disruptive behavior as a predictor in Alzheimer disease.Arch Neurol,64,1755.
34. Shinno, H,Inami, Y,Inagaki, T(2008).Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.Prog Neuropsychopharmacol Biol Psychiatry.,32,881-885.
35. Sink, KM,Covinsky, KE,Newcomer, R,Yaffe, K(2004).Ethnic differences in the prevalence and pattern of dementia-related behaviors.J Am Geriatr Soc,52,1277.
36. Suzuki, T,Futami, S,Igari, Y,Matsumura, N,Watanabe, K,Nakano, H,Oba, K,Murata, Y,Koibuchi, H,Kigawa, Y(2005).A Chinese herbal medicine, choto-san, improves cognitive function and activities of daily living of patients with dementia: a double-blind, randomized, placebo-controlled study.J Am Geriatr Soc.,53(12),2238-40.
37. 劉敏、閆軍堂、郭少英(2012)。王慶國運用麻黃細辛附子湯經驗。中醫雜誌，9，790-791。

1. 曾育慧,陳品璇,許中華(2022)。中醫居家醫療之現況與展望。台灣公共衛生雜誌，41(1)，16-35。
2. 楊鈞皓,陳安履,施怡伶,林舜穀,周暉哲(2018)。人參養榮湯減少失智患者憂鬱症狀並提供認知能力。台北市中醫醫學雜誌，24(1)，21-24。
3. 楊鈞皓,郭晨榆,林舜穀,李和蓁(2017)。台北市衛生局失智培訓案例討論－中醫介入的適當時機。台北市中醫醫學雜誌，23(4)，17-21。